diseases may reflect damage to the endothelial cell.3 As most inpatients lie quietly on a bed, and most outpatients are subject to movement during their clinic visits we sought to determine whether differences in vWFAg between these groups might be due to posture and activity. We tested the effect of different postures on circulating levels ofvWFAg in healthy hospital and laboratory staff. In the first study blood was taken into an EDTA tube from a group of five men and five women (mean age 29 (SD 5) years) immediately after normal kinetic laboratory activity. After resting quietly in the sitting position for 15 minutes, blood was taken from the opposite arm. Plasma was obtained after centrifugation at 3000 rpm for 10 minutes and vWFAg estimated by enzyme linked immunosorbent assay (ELISA).4 Mean (SD) concentrations of vWFAg immediately after activity were 1160 IU/1, (150), but after the rest period they had fallen to 1040 (220) (p<0'05), Wilcoxon rank sum test applied).
In a separate study six men and five women (aged 22-38) were rested lying down, face up, for 25 minutes, after which blood was taken. They then sat upright in a chair for a further 25 minutes and blood was taken a second time. After 25 minutes lying down plasma vWFAg concentrations were 950 (270) IU/1, but after 25 minutes sitting up levels increased to 1070 (200) IU/I (p<0O05).
This small study identified -changes in vWFAg concentrations depending upon variations in posture and activity. As vWFAg has been shown to rise after exercise5 this finding is not surprising. It points, however, to a possible artefact in vWFAg determination in patients. This may become important in the case of patients with, for example, rheumatoid arthritis, who are often admitted to hospital for bed rest. Reductions in vWFAg in these patients may reflect their posture and not necessarily reduced activation/injury of the endothelium. To avoid the possible problem in outpatient clinics we suggest that patients rest sitting for a minimum of 15 minutes before venepuncture. Despite the high prevalence of opportunistic infections in patients with AIDS, associated hypertrophic osteoarthropathy has rarely been reported. We present a patient with AIDS who developed severe rapidly progressive hypertrophic osteoarthropathy concurrently with anaerobic necrotising pneumonitis. A 29 year old man, an intravenous drug and alcohol abuser, known to be HIV positive, was admitted owing to development of severe pain and oedema in his arms and legs two months previously. He also complained of a persistent cough, with foul smelling sputum, occasionally haemoptoic, fever, and pleuritic chest pain. He had lost 10 kg of weight.
On admission, the patient appeared cachectic, was unable to walk, and had a temperature of 38-5°C. His mouth showed oropharyngeal candidiasis. Inspiratory rates were heard in the superior field of the right hemithorax. Heart sounds were normal, except for rhythmic tachycardia. The liver was felt 5 cm under the costal margin. There was no splenomegaly and diseased lymph nodes were not palpable. Both forearms, hands, legs, and feet showed prominent oedema, localwarmth, perspiration, and tenderness to pressure. Osteoarticular examination disclosed prominent clubbing of the fingers and toes, as well as synovitis, with moderate effusion ofthe knees, ankles, elbows, wrists, and proximal interphalangeal joints of the hands.
Blood studies showed haemoglobin 90 g/l, leucocytes 7'3x 109/l (lymphocytes 1%565x 109/l CD4+ 0-55x 109/l, CD4+/CD8+ ratio 0-5), platelets 367x109/1, erythrocyte sedimentation rate 105 mm/h. Serum alkaline phosphatase was 425 U/l (normal <279). Results of other routine tests were normal, including calcium, phosphorus, creatinine, glucose, aspartate transaminase, alanine transaminase, and lactate dehydrogenase.
Urine analysis results were also normal.
